November 26

BIOLQ · OTC

$0.00−$0.0001 (−99.00%)TodayMarket closed ·
No price history for this range.

About BIOLQ

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. The company is headquartered in Foothill Ranch, California and currently employs 157 full-time employees. The firm has no assets.

Employees
157
Headquarters
Foothill Ranch, California
Listed
Nov 12, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies

BIOLQ key statistics

Market cap
37
Price-earnings ratio
-0.00
Dividend yield
—
Average volume
19.05K
Volume
4
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.0002
52 Week low
$0.00

November 26 (BIOLQ) at a glance

November 26 (BIOLQ) last traded at $0.00, with a market cap of 37 and a price-to-earnings ratio of 0.00.

Volume so far is 4 shares, below the average of 19.05K shares a day.

Over the past year November 26 has ranged from $0.00 to $0.0002, and now sits 0% of the way up that range.

November 26 met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY24 it reported -$0.08 per share against an estimate of -$0.0773.

BIOLQ earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 22.1% on average.

  1. Q3 FY22: reported -$110.00 per share against an estimate of -$86.86
  2. Q4 FY22: reported -$128.00 per share against an estimate of -$65.58
  3. Q1 FY23: reported -$18.00 per share against an estimate of -$20.26
  4. Q2 FY23: reported -$8.24 per share against an estimate of -$5.49
  5. Q3 FY23: reported -$3.89 per share against an estimate of -$1.91
  6. Q4 FY23: reported -$1.76 per share against an estimate of -$2.63
  7. Q1 FY24: reported -$0.36 per share against an estimate of -$0.1751
  8. Q2 FY24: reported -$0.08 per share against an estimate of -$0.0773

BIOLQ news

  • Press releasePRNewswire

    BIOLASE and MegaGen America Launch U.S. Commercial Collaboration to Advance "More Brilliant Dentistry Together"

  • Press releasePRNewswire

    MegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California Facility

  • Press releasePRNewswire

    BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

  • Press releasePRNewswire

    BIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025

  • Press releasePRNewswire

    BIOLASE Emerges Stronger Than Ever Under New Ownership by MegaGen Implant

Similar companies

Companies in the same industry as November 26

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.